000 | 01813 a2200577 4500 | ||
---|---|---|---|
005 | 20250513175329.0 | ||
264 | 0 | _c19990624 | |
008 | 199906s 0 0 eng d | ||
022 | _a0264-6021 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRaab, U | |
245 | 0 | 0 |
_aExpression of normal and truncated forms of human endoglin. _h[electronic resource] |
260 |
_bThe Biochemical journal _cMay 1999 |
||
300 |
_a579-88 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntigens, CD |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Membrane _xmetabolism |
650 | 0 | 4 |
_aCysteine _xgenetics |
650 | 0 | 4 | _aDimerization |
650 | 0 | 4 |
_aDisulfides _xmetabolism |
650 | 0 | 4 | _aEndoglin |
650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPeptide Fragments _xbiosynthesis |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aProtein Isoforms _xbiosynthesis |
650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
650 | 0 | 4 | _aReceptors, Cell Surface |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xbiosynthesis |
650 | 0 | 4 | _aReducing Agents |
650 | 0 | 4 |
_aSequence Deletion _xgenetics |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aTelangiectasia, Hereditary Hemorrhagic _xgenetics |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xmetabolism |
650 | 0 | 4 |
_aVaccinia virus _xgenetics |
650 | 0 | 4 |
_aVascular Cell Adhesion Molecule-1 _xbiosynthesis |
700 | 1 | _aVelasco, B | |
700 | 1 | _aLastres, P | |
700 | 1 | _aLetamendía, A | |
700 | 1 | _aCalés, C | |
700 | 1 | _aLanga, C | |
700 | 1 | _aTapia, E | |
700 | 1 | _aLópez-Bote, J P | |
700 | 1 | _aPáez, E | |
700 | 1 | _aBernabéu, C | |
773 | 0 |
_tThe Biochemical journal _gvol. 339 ( Pt 3) _gp. 579-88 |
|
999 |
_c10174800 _d10174800 |